Chris Albanese

The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells.

Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells.

Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1.

Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression.

E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination.

Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.

Regulation of airway smooth muscle cyclin D1 transcription by protein kinase C-delta.

Senescence and epigenetic dysregulation in cancer.

Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells.

Recent advances in inducible expression in transgenic mice.

Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways.

Spatially discrete, light-driven protein expression.

IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.

Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1.

Activation of transcription factors AP-1 and NF-kappa B in murine Chagasic myocarditis.

Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.

The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.

Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.

Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization.

AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter.

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth.

Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells.

The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.

Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice.

Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells.

Differential effects of 16alpha-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells.

Increased cyclin E expression may obviate the role of cyclin D1 during brain development in cyclin D1 knockout mice.

Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation.

beta-catenin signaling and regulation of cyclin D1 promoter in NRK-49F cells transformed by down-regulation of the tumor suppressor lysyl oxidase.

A study of cytotoxic synergy of UCN-01 and flavopiridol in syngeneic pair of cell lines.

Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: a mechanism involving the p38 MAP kinase and phosphorylation of ATF-2.

Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.

Cyclin and caveolin expression in an acute model of murine Chagasic myocarditis.

Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI.

Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells.

In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models.

Construction of a novel DNA decoy that inhibits the oncogenic beta-catenin/T-cell factor pathway.

p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.

Cell cycle regulatory proteins in the liver in murine Trypanosoma cruzi infection.

ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.

ErbB-2 induces bilateral adrenal pheochromocytoma formation in mice.

Regulation of host cell cyclin D1 by Trypanosoma cruzi in myoblasts.

Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection.

Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D1.

Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype.

A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1.

Chagas disease, adipose tissue and the metabolic syndrome.

Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2 x Pten(+/-) preclinical mouse model.

VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.

Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection.

Smad7 restricts melanoma invasion by restoring N-cadherin expression and establishing heterotypic cell-cell interactions in vivo.

Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway.

PPARδ activation acts cooperatively with 3-phosphoinositide-dependent protein kinase-1 to enhance mammary tumorigenesis.

Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation.

VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells.

ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells.

Glutamine and the tumor microenvironment: understanding the mechanisms that fuel cancer progression.

Response of adipose tissue to early infection with Trypanosoma cruzi (Brazil strain).

Recent developments in the interactions between caveolin and pathogens.

Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.

Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI.

The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis.

Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy.

Preclinical magnetic resonance imaging and systems biology in cancer research: current applications and challenges.

Small animal imaging of human disease: from bench to bedside and back.

Alterations in glucose homeostasis in a murine model of Chagas disease.

Dissecting the pathways that destabilize mutant p53: the proteasome or autophagy?

An expanded role for Caveolin-1 in brain tumors.

Therapeutic and space radiation exposure of mouse brain causes impaired DNA repair response and premature senescence by chronic oxidant production.

VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects.

Magnetic nanobeads as potential contrast agents for magnetic resonance imaging.

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.

The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells.

High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.

Integration of Network Biology and Imaging to Study Cancer Phenotypes and Responses.

Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.

The SLC25A1-p53 mutant crosstalk.

Manganese-Enhanced Magnetic Resonance Imaging as a Diagnostic and Dispositional Tool after Mild-Moderate Blast Traumatic Brain Injury.

Thermoresponsive release of viable microfiltrated Circulating Tumor Cells (CTCs) for precision medicine applications.

Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.

Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer.